Insmed (INSM) Exchange Rate Effect (2016 - 2026)
Insmed's (INSM) quarterly Exchange Rate Effect came in at -$553000.0 in Q1 2026, down 161.79% year-on-year from $895000.0 in Q1 2025, and down 8000.0% quarter-over-quarter from $7000.0 in Q4 2025.
Insmed (INSM) Exchange Rate Effect (2016 - 2026) Analysis & Trends
Insmed's Exchange Rate Effect history runs 11 years deep, the most recent figure standing at -$553000.0 for Q1 2026.
- On a quarterly basis, Exchange Rate Effect fell 161.79% year-over-year to -$553000.0 in Q1 2026; TTM through Mar 2026 was -$517000.0, a 195.56% decrease from a year earlier, with the FY2025 full-year figure at $931000.0, up 171.23% from the prior year.
- Exchange Rate Effect fell to -$553000.0 in Q1 2026 per INSM's latest filing, from $7000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $2.2 million in Q3 2023 and bottomed at -$3.4 million in Q2 2023.
- The 5-year median for Exchange Rate Effect is -$553000.0 (2026), against an average of -$127941.2.
- Across the five-year window, Exchange Rate Effect surged 501.08% in 2022 and slumped 3186.21% in 2024, its largest moves.
- Year by year, Exchange Rate Effect stood at -$1.1 million in 2022, then surged by 188.64% to $1.0 million in 2023, then slumped by 248.42% to -$1.5 million in 2024, then soared by 100.47% to $7000.0 in 2025, then tumbled by 8000.0% to -$553000.0 in 2026.
- Per Business Quant, the three latest INSM Exchange Rate Effect figures stand at -$553000.0 (Q1 2026), $7000.0 (Q4 2025), and -$976000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Insmed | 23.26 Bn | 22.03 Bn | 258.54 Mn | -553,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -553,000.00 |
| Mar 31, 2026 | -553,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Sep 30, 2025 | -976,000.00 |
| Sep 30, 2025 | -976,000.00 |
| Jun 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 1.01 Mn |
| Mar 31, 2025 | 895,000.00 |
| Mar 31, 2025 | 895,000.00 |
| Dec 31, 2024 | -1.51 Mn |
| Dec 31, 2024 | -1.51 Mn |
| Sep 30, 2024 | 1.84 Mn |
| Sep 30, 2024 | 1.84 Mn |
| Jun 30, 2024 | -688,000.00 |
| Jun 30, 2024 | -688,000.00 |
| Mar 31, 2024 | -953,000.00 |
| Mar 31, 2024 | -953,000.00 |
| Dec 31, 2023 | 1.01 Mn |
| Dec 31, 2023 | 1.01 Mn |